Mechanistically, we found that IL-1β is a key downstream gene affected by AK4, and AK4 may promote IL-1β release by activating the NLRP3 inflammasome signaling pathway binding with nicotinamide nucleotide transhydrogenase (NNT), thereby promoting invasion, migration, and chemoresistance of tumor cells. This evidence concerns the gene AK4 and neoplasm.